Clinical trials
Active, not recruiting Ovarian Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| City of Hope Medical Center | 2 |
| AGO Study Group | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Augusta University | 1 |
| Baltimore VA Medical Center | 1 |
| Comprehensive Support Project for Oncology Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 32 |
| Breast Neoplasms | 10 |
| Endometrial Neoplasms | 9 |
| Colonic Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Fallopian Tube Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.